AstraZeneca reported 4.19B in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbvie ABBV:US $ 7127M 482M
Alcon AG ALC:SW 566M 141M
Amgen AMGN:US $ 3341M 185M
AstraZeneca AZN:LN 4187M 687M
AstraZeneca AZN:SS SK 4187M 687M
Astrazeneca AZN:US $ 4187M 687M
Biogen BIIB:US $ 674.7M 20.2M
Bristol Myers Squibb BMY:US $ 5772M 404M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Fresenius FRE:GR € 1496M 212M
Fresenius Medical Care FME:GR € 852.14M 149.16M
Galapagos GLPG:NA € -15.63M 31.37M
Gilead Sciences GILD:US $ 3422M 1947M
GlaxoSmithKline GSK:LN 3120M 1062M
GRIFOLS GRF:SM € 329.18M 78.53M
H. Lundbeck A/S LUN:DC 1.29B 850M
Hikma Pharmaceutical HIK:LN 368M 10M
Lonza Group LONN:SW 789M 58M
Merck MRK:GR € 1630M 173M
Merk MRK:US $ 6179M 492M
Novartis NOVN:VX SF 4552M 346M
Orion ORNBV:FH € 83M 34.6M
Pfizer PFE:US $ 11182M 4046M
Philips PHIA:NA € 598M 400M
Recordati REC:IM € 163.05M 8.44M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M